Lonza is thriving today and will gain even more competitive advantages going forward because we excel at transferring knowledge, experience, technology and best-in-class practices across our businesses.
The quest to capitalize on cross-business synergies is embodied in the challenge that our CEO has issued repeatedly in recent years – “If Lonza only knew what Lonza knows!”
Applying Knowledge Across the Businesses
We are bridging the gaps in knowledge between businesses, functions and technologies in many ways, including simple things such as using electronic laboratory notebooks that can be broadly accessed by Lonza researchers so that they can benefit from each others’ work. As another example, we have deployed a new global quality organization that will make it easier to share quality, error prevention and regulatory excellence practices across the entire company.
The value of cross-business synergies is vividly apparent in two vital goals of the Capsugel integration: to generate CHF 100 million in additional, synergistic sales per year by 2022 and CHF 30 million in operational and CHF 15 million in tax savings by 2020. We are already well on track toward achieving those goals.